Literature DB >> 24717920

Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.

Wei-Sheng Chung1, Cheng-Li Lin1, Fung-Chang Sung1, Wu-Huei Hsu2, Wen-Ta Yang2, Chuan-Chin Lu2, Chia-Hung Kao3.   

Abstract

OBJECTIVES: Few Asian studies have evaluated the risks of deep vein thrombosis (DVT) and pulmonary thromboembolism (PTE) in patients with SSc. We conducted a nationwide population-based cohort study to evaluate how SSc affected the incidence of DVT and PTE in Taiwan.
METHODS: We identified patients with an SSc diagnosis in Taiwan between 1998 and 2010 using the Catastrophic Illness Patient Database and the National Health Insurance Research Database. Each SSc patient was frequency matched to four control patients based on age, sex and index year and all patients were observed from the index date until the appearance of a DVT or PTE event or 31 December 2010. We calculated the hazard ratios and 95% CIs of DVT and PTE in the SSc and comparison cohorts using the Cox proportional hazards regression model.
RESULTS: We observed 1895 SSc patients and 7580 control patients for ∼10,128 and 46,488 person-years, respectively. The mean ages of the SSc and comparison cohorts were 50.3 and 49.9 years, respectively. After adjusting for age, sex and co-morbidities, the risks of DVT and PTE among the SSc patients were 10.5- and 7.00-fold higher than those of the control patients. The probability of developing DVT and PTE increased in the years following the SSc diagnosis.
CONCLUSION: SSc patients exhibited a significantly higher risk of developing DVT and PTE compared with the general population. Thus multidisciplinary teams should guide the assessment, treatment and holistic care of SSc patients.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  deep vein thrombosis; nationwide cohort study; pulmonary thromboembolism; systemic sclerosis

Mesh:

Year:  2014        PMID: 24717920     DOI: 10.1093/rheumatology/keu133

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

1.  Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis.

Authors:  Mathieu Jouvray; David Launay; Sylvain Dubucquoi; Vincent Sobanski; Céline Podevin; Marc Lambert; Sandrine Morell-Dubois; Hélène Maillard; Pierre-Yves Hatron; Eric Hachulla; Jonathan Giovannelli
Journal:  JAMA Dermatol       Date:  2018-07-01       Impact factor: 10.282

Review 2.  An Update on Systemic Sclerosis and its Perioperative Management.

Authors:  Zyad J Carr; John Klick; Brittany J McDowell; Jean G Charchaflieh; Kunal Karamchandani
Journal:  Curr Anesthesiol Rep       Date:  2020-08-29

3.  Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study.

Authors:  Sara R Schoenfeld; Hyon K Choi; Eric C Sayre; J Antonio Aviña-Zubieta
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-02       Impact factor: 4.794

4.  A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases.

Authors:  Jason J Lee; Janet E Pope
Journal:  Arthritis Res Ther       Date:  2014-09-25       Impact factor: 5.156

Review 5.  Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights.

Authors:  Paola Faverio; Federica De Giacomi; Giulia Bonaiti; Anna Stainer; Luca Sardella; Giulia Pellegrino; Giuseppe Francesco Sferrazza Papa; Francesco Bini; Bruno Dino Bodini; Mauro Carone; Sara Annoni; Grazia Messinesi; Alberto Pesci
Journal:  Int J Med Sci       Date:  2019-06-10       Impact factor: 3.738

Review 6.  Adipocytokines: Are they the Theory of Everything?

Authors:  Pierre S Maximus; Zeina Al Achkar; Pousette F Hamid; Syeda S Hasnain; Cesar A Peralta
Journal:  Cytokine       Date:  2020-06-16       Impact factor: 3.861

Review 7.  The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis.

Authors:  Michael H Lee; Todd M Bull
Journal:  F1000Res       Date:  2019-12-19

8.  The Incidence of Deep Vein Thrombosis in Asian Patients With Chronic Obstructive Pulmonary Disease.

Authors:  Chung-Yu Chen; Kuang-Ming Liao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.